WHO ICTRP trial
The impact of amlodipine based treatment on TTR in Chinese adult hypertensive…
ChiCTR2400090150 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400090150 |
|---|---|
| Public title | The impact of amlodipine based treatment on TTR in Chinese adult hypertensive patients: a database analysis project |
| Scientific title | Analysis of the current situation of blood pressure target range time in Chinese hypertensive patients based on amlodipine as the basic treatment plan: a retrospective data analysis project based on a database |
| Primary sponsor | Peking University People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | hypertension |
| Interventions | Case series:NA |
| Registration date | Sep 25, 2024 |
| Target size | Case series:36000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: